Wenbin Jiang, President and CEO at Cytek Biosciences, Inc. (CTKB), sold 20,000 shares at $8.23 ($165K) on 2023-06-07, disclosed to the SEC on 2023-06-07.
Scheduled sale ($165k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTKB | SELL | 2023-09-08 | $137K | — | Filing → |
| CTKB | SELL | 2023-08-08 | $362K | — | Filing → |
| CTKB | SELL | 2023-07-07 | $170K | — | Filing → |